ATM and neoplasm: We found that tumors with new pathogenic ATM missense mutations were significantly associated with improved irradiated tumor control than those with benign missense mutations, according to a multivariable model (hazard ratio, 0.58 [95% CI, 0.35 to 0.95]; P = .03, Fig 4C, Data Supplement, Table S9).